Amy L. Ronneberg
CIK: 0001380292
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACTU
ACTUATE THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
About RONNEBERG AMY L
RONNEBERG AMY L (SEC CIK 0001380292) files insider reports with the SEC as Director of ACTUATE THERAPEUTICS, INC. (ACTU).
Signal8 holds 2 ownership filings by RONNEBERG AMY L, all Form 4s, filed between May 23, 2025 and May 22, 2026. Those filings report 2 transactions, from May 22, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RONNEBERG AMY L's filings is in FORT WORTH, TX.
Recent filings by RONNEBERG AMY L
Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)
- THOMSON TODD S, Director
- BIOS Fund III, LP, Director
- BIOS Fund I, LP, Director
- SCHMITT DANIEL M, President, CEO and Director
- Zabrowski Dan, Director
- Sawhney Roger, Director